Successful pharmaceutical and biotech firms linked to the Medical Research Council have landed at least £6 billion in investment since 2008, and more before then, study finds
Indexed fees and some movement on student maintenance seen as key goals for coming spending review, with economic climate reducing chances of more systemic reform